Pathogen evolution and the immunological niche

Annals of the New York Academy of Sciences

Volumn 1320, Issue 1, 2014, Pages 1-15

  Cobey, Sarah ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bacteria; Evolutionary epidemiology; Host pathogen interactions; Infectious diseases; Influenza; Niche theory; Phylodynamics; Viruses

Indexed keywords

VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; EVOLUTION; EVOLUTIONARY ADAPTATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; IMMUNOLOGICAL NICHE; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; NONHUMAN; PATHOGEN EVOLUTION; PATHOGENESIS; PHENOTYPE; SPECIES COEXISTENCE;

BACTERIA; EVOLUTIONARY EPIDEMIOLOGY; HOST-PATHOGEN INTERACTIONS; INFECTIOUS DISEASES; INFLUENZA; NICHE THEORY; PHYLODYNAMICS; VIRUSES;

ANIMALS; BIOLOGICAL EVOLUTION; COMMUNICABLE DISEASES; GENETIC VARIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; PHENOTYPE; SELECTION, GENETIC; STEM CELL NICHE; VACCINES;

EID: 84904390863     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12493     Document Type: Article

References (163)

1. Grenfell, B.T., O.G. Pybus, J.R. Gog, et al. 2004. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303: 327-332.
2. Domingo, E., J. Sheldon & C. Perales . 2012. Viral quasispecies evolution. Microbiol. Mol. Biol. Rev. 76: 159-216.
3. Coleman, J.R., D. Papamichail, S. Skiena, et al. 2008. Virus attenuation by genome-scale changes in codon pair bias. Science 320: 1784-1787.
4. Crotty, S., C.E. Cameron & R. Andino . 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U.S.A. 98: 6895-6900.
5. Akira, S., S. Uematsu & O. Takeuchi . 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
6. Hyams, C., E. Camberlein, J.M. Cohen, et al. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect. Immun. 78: 704-715.
7. Domenico, P., R.J. Salo, A.S. Cross & B.A. Cunha . 1994. Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae. Infect. Immun. 62: 4495-4499.
8. Lipsitch, M. & J.J. O'Hagan . 2007. Patterns of antigenic diversity and the mechanisms that maintain them. J. R. Soc. Interf. 4: 787-802.
9. Foster, T.J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3: 948-958.
10. Fitzgerald, T.J. & R.C. Johnson . 1979. Surface mucopolysaccharides of Treponema pallidum. Infect Immun. 24: 244-251.
11. Regoes, R.R., S. Hamblin & M.M. Tanaka . 2013. Viral mutation rates: modelling the roles of within-host viral dynamics and the trade-off between replication fidelity and speed. Proc. Biol. Sci. R. Soc. 280: 2012-2047.
12. Thomas, P.G., R. Keating, D.J. Hulse-Post & P.C. Doherty . 2006. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 12: 48-54.
13. Cutts, F.T., S. Franceschi, S. Goldie, et al. 2007. Human papillomavirus and HPV vaccines: a review. Bull. World Health Org. 85: 719-726.
14. Doorbar, J. 2005. The papillomavirus life cycle. J. Clin. Virol. 32 Suppl 1:S7-S15.
15. Rasaiyaah, J., C.P. Tan, A.J. Fletcher, et al. 2013. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503: 402-405.
16. Garcia-Sastre, A, R.K. Durbin, H. Zheng, et al. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72: 8550-8558.
17. Kochs, G., A. Garcia-Sastre & L. Martinez-Sobrido . 2007. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 81: 7011-7021.
18. Lin, A., J.A. Loughman, B.H. Zinselmeyer, et al. 2009. Streptolysin S inhibits neutrophil recruitment during the early stages of Streptococcus pyogenes infection. Infect. Immun. 77: 5190-5201.
19. Dagna, L., J.C. Pritchett & P. Lusso . 2013. Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol. 8: 273-287.
20. Spencer, J.V., K.M. Lockridge, P.A. Barry, et al. 2002. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76: 1285-1292.
21. Biegalke, B.J., E. Lester, A. Branda & R. Rana . 2004. Characterization of the human cytomegalovirus UL34 gene. J. Virol. 78: 9579-9583.
22. Molina-Cruz, A., L.S. Garver, A. Alabaster, et al. 2013. The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system. Science 340: 984-987.
23. Hurford, A. & T. Day . 2013. Immune evasion and the evolution of molecular mimicry in parasites. Evolution: Int. J. Organ. Evol. 67: 2889-2904.
24. Bedford, T., M.A. Suchard, P. Lemey, et al. 2014. Integrating influenza antigenic dynamics with molecular evolution. eLife 3: e01914.
25. Rambaut, A., O.G. Pybus, M.I. Nelson, et al. 2008. The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615-620.
26. Bedford, T., S. Cobey & M. Pascual . 2011. Strength and tempo of selection revealed in viral gene genealogies. BMC Evolut. Biol. 11: 220.
27. Hensley, S.E., S.R. Das, A.L. Bailey, et al. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736.
28. Fitch, W.M., R.M. Bush, C.A. Bender & N.J. Cox . 1997. Long term trends in the evolution of H(3) HA1 human influenza type A. Proc. Natl. Acad. Sci. U. S. A. 94: 7712-7718.
29. Das, S.R., P. Puigbo, S.E. Hensley, et al. 2010. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog. 6: e1001211.
30. Luksza, M. & M. Lassig . 2014. A predictive fitness model for influenza. Nature 507: 57-61.
31. Buckee, C.O., K.A. Jolley, M. Recker, et al. 2008. Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc. Natl. Acad. Sci. U.S.A. 105: 15082-15087.
32. Li, Y., T. Gierahn, C.M. Thompson, et al. 2012. Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. PLoS Pathog. 8: e1002989.
33. Debbink, K., L.C. Lindesmith, E.F. Donaldson, et al. 2013. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J. Infect. Dis. 208: 1877-1887.
34. Liao, H.X., R. Lynch, T. Zhou, et al. 2013. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496: 469-476.
35. Bar, K.J., C.Y. Tsao, S.S. Iyer, et al. 2012. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog. 8: e1002721.
36. Tee, K.K., T.T. Lam, Y.F. Chan, et al. 2010. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J. Virol. 84: 3339-3350.
37. Mackinnon, M.J. & K. Marsh . 2010. The selection landscape of malaria parasites. Science 328: 866-871.
38. Emes, R.D. & Z. Yang . 2008. Duplicated paralogous genes subject to positive selection in the genome of Trypanosoma brucei. PloS One 3: e2295.
39. + T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 79: 13239-13249.
40. Ganusov, V.V., N. Goonetilleke, M.K. Liu, et al. 2011. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J. Virol. 85: 10518-10528.
41. Poon, A.F., S.L. Kosakovsky Pond, P. Bennett, et al. 2007. Adaptation to human populations is revealed by within-host polymorphisms in HIV-1 and hepatitis C virus. PLoS Pathog. 3: e45.
42. + immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus. Hepatology 44: 736-745.
43. Gog, J.R., G.F. Rimmelzwaan, A.D.M.E. Osterhaus & B.T. Grenfell . 2003. Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc. Natl. Acad. Sci. U. S. A. 100: 11143-11147.
44. Suzuki, Y. 2006. Natural selection on the influenza virus genome. Mol. Biol. Evol. 23: 1902-1911.
45. Gupta, A., A. Kaul, A.G. Tsolaki, et al. 2012. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 217: 363-374.
46. Pepperell, C.S., A.M. Casto, A. Kitchen, et al. 2013. The role of selection in shaping diversity of natural M. tuberculosis populations. PLoS Pathog. 9: e1003543.
47. Baranowski, E., C.M. Ruiz-Jarabo & E. Domingo . 2001. Evolution of cell recognition by viruses. Science 292: 1102-1105.
48. Recker, M., C.O. Buckee, A. Serazin, et al. 2011. Antigenic variation in Plasmodium falciparum malaria involves a highly structured switching pattern. PLoS Pathog. 7: e1001306.
49. Santibanez, S., S. Niewiesk, A. Heider, et al. 2005. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J. Gen. Virol. 86: 365-374.
50. Mitnaul, L.J., M.N. Matrosovich, M.R. Castrucci, et al. 2000. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74: 6015-6020.
51. Ndifon, W., N.S. Wingreen & S.A. Levin . 2009. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl. Acad. Sci. U. S. A. 106: 8701-8706.
52. Povolotskaya, I.S. & F.A. Kondrashov . 2010. Sequence space and the ongoing expansion of the protein universe. Nature 465: 922-926.
53. Szendro, I.G., M.F. Schenk, J. Franke, J. Krug, et al. 2013. Quantitative analyses of empirical fitness landscapes. J. Stat. Mech. P01005 doi:10.1088/1742-5468/2013/01/P01005.
54. Cobey, S. & K. Koelle . 2008. Capturing escape in infectious disease dynamics. Trends Ecol. Evol. 23: 572-577.
55. Chu, P.Y., G.M. Ke, P.C. Chen, et al. 2013. Spatiotemporal dynamics and epistatic interaction sites in dengue virus type 1: a comprehensive sequence-based analysis. PloS One 8: e74165.
56. Alexander, C. & E.T. Rietschel . 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7: 167-202.
57. Murphy K. 2012. "Janeway's immunobiology." In Garland Sciences. 8th ed. C. Murphy, Ed.: 202-216, 412-413. New York: Taylor & Francis Group, LLC.
58. Baccam, P., C. Beauchemin, C.A. Macken, et al. 2006. Kinetics of influenza A virus infection in humans. J. Virol. 80: 7590-7599.
59. Van Reeth, K. 2000. Cytokines in the pathogenesis of influenza. Veterin. Microbiol. 74: 109-116.
60. Maruyama, M., K.P. Lam & K. Rajewsky . 2000. Memory B-cell persistence is independent of persisting immunizing antigen. Nature 407: 636-642.
61. Cobey, S. & M. Lipsitch . 2013. Pathogen diversity and hidden regimes of apparent competition. Amer. Natur. 181: 12-24.
62. Lloyd-Smith, J.O. 2013. Vacated niches, competitive release and the community ecology of pathogen eradication. Philos. Trans. R Soc. Lond. B Biol. Sci. 368: 20120150.
63. Barabas, G., G. Meszena & A. Ostling . 2012. Community robustness and limiting similarity in periodic environments. Theor. Ecol. 5: 265.
64. Szilagyi, A. & G. Meszena . 2009. Limiting similarity and niche theory for structured populations. J. Theor. Biol. 258: 27-37.
65. Meszena, G., M. Gyllenberg, L. Pasztor & J.A. Metz . 2006. Competitive exclusion and limiting similarity: a unified theory. Theor. Populat. Biol. 69: 68-87.
66. Lapedes, A. & R. Farber . 2001. The geometry of shape space: application to influenza. J. Theoret. Biol. 212: 57-69.
67. Smith, D.J., A.S. Lapedes, J.C. de Jong, et al. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
68. Grund, S., O. Adams, S. Wahlisch & B. Schweiger . 2011. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J. Virol. Meth. 171: 369-373.
69. Katz, J.M., K. Hancock & X. Xu . 2011. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev. Anti-infect. Ther. 9: 669-683.
70. Underwood, P.A. 1980. Serology and energetics of cross-reactions among the H-3 antigens of influenza-viruses. Infect. Immun. 27: 397-404.
71. Rimmelzwaan, G.F., J.H. Kreijtz, R. Bodewes, et al. 2009. Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine 27: 6363-6365.
72. Recker, M., O.G. Pybus, S. Nee & S. Gupta . 2007. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc. Natl. Acad. Sci. U.S.A. 104: 7711-7716.
73. Buckee, C.O., P.C. Bull & S. Gupta . 2009. Inferring malaria parasite population structure from serological networks. Proc. Biol. Sci.: R. Soc. 276: 477-485.
74. Crowe, S.R., S.J. Turner, S.C. Miller, et al. 2003. Differential antigen presentation regulates the changing patterns of CD8(+) T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198: 399-410.
75. Cobey, S. & M. Pascual . 2011. Consequences of host heterogeneity, epitope immunodominance, and immune breadth for strain competition. J. Theor. Biol. 270: 80-87.
76. Wrammert, J., D. Koutsonanos, G.M. Li, et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208: 181-193.
77. Welsh, R.M., J.W. Che, M.A. Brehm & L.K. Selin . 2010. Heterologous immunity between viruses. Immunol. Rev. 235: 244-266.
78. Li, Y., J.L. Myers, D.L. Bostick, et al. 2013. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J. Exp. Med. 210: 1493-1500.
79. Wherry, E.J., J.N. Blattman, K. Murali-Krishna, et al. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
80. Goronzy, J.J. & C.M. Weyand . 2013. Understanding immunosenescence to improve responses to vaccines. Nature Immunol. 14: 428-436.
81. Malley, R., M. Lipsitch, D. Bogaert, et al. 2007. Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease. J. Infect. Dis. 196: 928-935.
82. Ferreira, D.M., D.R. Neill, M. Bangert, et al. 2013. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am. J. Respir. Crit. Care Med. 187: 855-864.
83. Ng, S., V.J. Fang, D.K. Ip, et al. 2013. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J. Infect. Dis. 208: 1320-1324.
84. Ohmit, S.E., J.G. Petrie, R.T. Cross, et al. 2011. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J. Infect. Dis. 204: 1879-1885.
85. Weinberger, D.M., R. Dagan, N. Givon-Lavi, et al. 2008. Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J. Infect. Dis. 197: 1511-1518.
86. Hobson, D., R.L. Curry, A.S. Beare & A. Ward-Gardner . 1972. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 70: 767-777.
87. Tate, M.D., A.G. Brooks & P.C. Reading . 2008. The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir. Res. 9: 57.
88. Ferguson, N.M., A.P. Galvani & R.M. Bush . 2003. Ecological and immunological determinants of influenza evolution. Nature 422: 428-433.
89. Ganusov, V.V., R.A. Neher & A.S. Perelson . 2013. Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses. J. Statist. Mech. 2013: P01010.
90. Kermack, W.O. & A.G. McKendrick . 1927. A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. Ser. A 115: 700-721.
91. Keeling, M.J. & P. Rohani . 2007. Modeling Infectious Diseases in Humans and Animals. Princeton, NJ: Princeton University Press.
92. Gupta, S., N.M. Ferguson & R.M. Anderson . 1998. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 280: 912-915.
93. Andreasen, V., J. Lin & S.A. Levin . 1997. The dynamics of cocirculating influenza strains conferring partial cross-immunity. J. Math. Biol. 35: 825-842.
94. Chesson, P. 2000. Mechanism of maintenance of species diversity. Annu. Rev. Ecol. Syst. 31: 343-366.
95. Reich, N.G., S. Shrestha, A.A. King, et al. 2013. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J. R. Soc. Interf. 10: 20130414.
96. Koelle, K., M. Pascual & M. Yunus . 2006. Serotype cycles in cholera dynamics. Proc. R. Soc. B-Biol. Sci. 273: 2879-2886.
97. Agur, Z., D. Abiri & L.H. Van der Ploeg . 1989. Ordered appearance of antigenic variants of African trypanosomes explained in a mathematical model based on a stochastic switch process and immune-selection against putative switch intermediates. Proc. Natl. Acad. Sci. U.S.A. 86: 9626-9630.
98. Gog, J.R. & B.T. Grenfell . 2002. Dynamics and selection of many-strain pathogens. Proc. Natl. Acad. Sci. U. S. A. 99: 17209-17214.
99. Omori, R., B. Adams & A. Sasaki . 2010. Coexistence conditions for strains of influenza with immune cross-reaction. J. Theor. Biol. 262: 48-57.
100. Bedford, T., A. Rambaut & M. Pascual . 2012. Canalization of the evolutionary trajectory of the human influenza virus. BMC Biol. 10: 38.
101. Koelle, K., S. Cobey, B. Grenfell & M. Pascual . 2006. Epochal evolution shapes the phylodynamics of interpandemic influenza. Science 314: 1898-1903.
102. Zinder, D., T. Bedford, S. Gupta & M. Pascual . 2013. The roles of competition and mutation in shaping antigenic and genetic diversity in influenza. PLoS Pathog. 9: e1003104.
103. Chen, R.B. & E.C. Holmes . 2008. The evolutionary dynamics of human influenza B virus. J. Mol. Evol. 66: 655-663.
104. Tria, F., M. Lassig, L. Peliti & S. Franz . 2005. A minimal stochastic model for influenza evolution. J. Stat. Mech. Theory E. P07008 doi:10.1088/1742-5468/2005/07/P07008.
105. Hutchinson, G.E. 1957. Concluding remarks. Cold Spring Harbor Symposium. Quantit. Biol. 22: 415-427.
106. Goldstein, E., S. Cobey, S. Takahashi, et al. 2011. Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS Med. 8: e1001051.
107. + T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity. PLoS Pathog. 9: e1003207.
108. Finkelman, B.S., C. Viboud, K. Koelle, et al. 2007. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PloS One 2: e1296.
109. Gause, G.F. 1932. Experimental studies on the struggle for existence. I. Mixed population of two species of yeast. J. Exp. Biol. 9: 389-402.
110. Cobey, S. & M. Lipsitch . 2012. Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335: 1376-1380.
111. Weinberger, D.M., K. Trzcinski, Y.J. Lu, et al. 2009. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 5: e1000476.
112. Lipsitch, M., O. Abdullahi, A. D'Amour, et al. 2012. Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Epidemiology 23: 510-519.
113. Flasche, S., W.J. Edmunds, E. Miller, D. Goldblatt, C. Robertson & Y.H. Choi . 2013. The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination. Proc. Biol. Sci.: R. Soc. 280: 20131939.
114. + T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. U. S. A. 102: 4848-4853.
115. Hogberg, L., P. Geli, H. Ringberg, et al. 2007. Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J. Clin. Microbiol. 45: 948-952.
116. Adler, P.B., J. Hillerislambers & J.M. Levine . 2007. A niche for neutrality. Ecol. Lett. 10: 95-104.
117. Wendelboe, A.M., A. Van Rie, S. Salmaso & J.A. Englund . 2005. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 24: S58-S61.
118. Lipsitch, M. 1997. Vaccination against colonizing bacteria with multiple serotypes. Proc. Natl. Acad. Sci. U.S.A. 94: 6571-6576.
119. Lipsitch, M. 1999. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg. Infect. Dis. 5: 336-345.
120. Lee, C.W., D.A. Senne & D.L. Suarez . 2004. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J. Virol. 78: 8372-8381.
121. Rinta-Kokko, H., R. Dagan, N. Givon-Lavi & K. Auranen . 2009. Estimation of vaccine efficacy against acquisition of pneumococcal carriage. Vaccine 27: 3831-3837.
122. Hanage, W.P., J.A. Finkelstein, S.S. Huang, et al. 2010. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2: 80-84.
123. Witt, M.A., P.H. Katz & D.J. Witt . 2012. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin. Infect. Dis. 54: 1730-1735.
124. Lavine, J.S., A.A. King & O.N. Bjornstad . 2011. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc. Natl. Acad. Sci. U.S.A. 108: 7259-7264.
125. Cowling, B.J., V.J. Fang, H. Nishiura, et al. 2012. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin. Infect. Dis. 54: 1778-1783.
126. Smith, A.M., F.R. Adler, R.M. Ribeiro, et al. 2013. Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog. 9: e1003238.
127. Bodewes, R., J.H. Kreijtz, M.M. Geelhoed-Mieras, et al. 2011. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J. Virol. 85: 2695-2702.
128. Bodewes, R., J.H. Kreijtz, M.L. Hillaire, et al. 2010. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice. J. Gen. Virol. 91: 1743-1753.
129. Bodewes, R., P.L. Fraaij, J.H. Kreijtz, et al. 2012. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 30: 7407-7410.
130. Neuman de Vegvar, H.E., R.R. Amara, L. Steinman, et al. 2003. Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J. Virol. 77: 11125-11138.
131. Stephens, R., R.L. Culleton & T.J. Lamb . 2012. The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol. 28: 73-82.
132. Miller, M.S., T.J. Gardner, F. Krammer, et al. 2013. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci. Translat. Med. 5: 198ra07.
133. Jiang, N., J. He, J.A. Weinstein, et al. 2013. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci. Translat. Med. 5: 171ra19.
134. Li, G.M., C. Chiu, J. Wrammert, et al. 2012. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. U.S.A. 109: 9047-9052.
135. Koelle, K., P. Khatri, M. Kamradt & T.B. Kepler . 2010. A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J. R. Soc. Interf. 7: 1257-1274.
136. Kessinger, T.A., A.S. Perelson & R.A. Neher . 2013. Inferring HIV escape rates from multi-locus genotype data. Front. Immunol. 4: 252.
137. Abrams, P. 1983. The theory of limiting similarity. Annu. Rev. Ecol. Systemat. 14: 359-376.
138. Polis, GA & D.R. Strong . 1996. Food web complexity and community dynamics. Amer. Natural. 147: 813-846.
139. Bloom, J.D., L.I. Gong & D. Baltimore . 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272-1275.
140. Jimenez, J.I., R. Xulvi-Brunet, G.W. Campbell, et al. 2013. Comprehensive experimental fitness landscape and evolutionary network for small RNA. Proc. Natl. Acad. Sci. U.S.A. 110: 14984-14989.
141. Ferguson, A.L., J.K. Mann, S. Omarjee, et al. 2013. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity 38: 606-617.
142. Graham, A.L., A.D. Hayward, K.A. Watt, et al. 2010. Fitness correlates of heritable variation in antibody responsiveness in a wild mammal. Science 330: 662-665.
143. Cooper, G.S., M.L. Bynum & E.C. Somers . 2009. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J. Autoimmun. 33: 197-207.
144. Childs, L.M., N.L. Held, M.J. Young, et al. 2012. Multiscale model of CRISPR-induced coevolutionary dynamics: diversification at the interface of Lamarck and Darwin. Evol.: Int. J. Org. Evol. 66: 2015-2029.
145. To, K.K., A.J. Zhang, I.F. Hung, et al. 2012. High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. Clin. Vaccine Immunol. 19: 1012-1018.
146. Crowe, S.R., S.C. Miller & D.L. Woodland . 2006. Identification of protective and non-protective T cell epitopes in influenza. Vaccine 24: 452-456.
147. Khurana, S., C.L. Loving, J. Manischewitz, et al. 2013. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Sci. Translat. Med. 5: 200ra114.
148. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. U.S.A. 93: 14076-14081.
149. + T cells with stem cell-like properties. Nature Med. 20: 139-142.
150. Shannon-Lowe, C.D., B. Neuhierl, G. Baldwin, et al. 2006. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 103: 7065-7070.
151. Lipsitch, M., C. Colijn, T. Cohen, et al. 2009. No coexistence for free: neutral null models for multistrain pathogens. Epidemics 1: 2-13.
152. Lin, J., V. Andreasen & S.A. Levin . 1999. Dynamics of influenza A drift: the linear three-strain model. Math. Biosci. 162: 33-51.
153. Gog, J.R. & J. Swinton . 2002. A status-based approach to multiple strain dynamics. J. Math. Biol. 44: 169-184.
154. Kryazhimskiy, S., U. Dieckmann, S.A. Levin & J. Dushoff . 2007. On state-space reduction in multi-strain pathogen models, with an application to antigenic drift in influenza A. Plos Computat. Biol. 3: 1513-1525.
155. Koelle, K., X. Rodo, M. Pascual, et al. 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436: 696-700.
156. King, A.A., E.L. Ionides, M. Pascual & M.J. Bouma . 2008. Inapparent infections and cholera dynamics. Nature 454: 877-880.
157. Knossow, M., M. Gaudier, A. Douglas, et al. 2002. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302: 294-298.
158. Fitch, W.M., J.M.E. Leiter, X. Li & P. Palese . 1991. Positive Darwinian evolution in human influenza A viruses. Proc. Natl. Acad. Sci. U. S. A. 88: 4270-4274.
159. Phillips, R.E., S. Rowland-Jones, D.F. Nixon, et al. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459.
160. Lewis-Rogers, N., M.L. Bendall & K.A. Crandall . 2009. Phylogenetic relationships and molecular adaptation dynamics of human rhinoviruses. Mol. Biol. Evol. 26: 969-981.
161. Taniguchi, K., W.L. Maloy, K. Nishikawa, et al. 1988. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J. Virol. 62: 2421-2426.
162. Andrews, T.D. & T. Gojobori . 2004. Strong positive selection and recombination drive the antigenic variation of the PilE protein of the human pathogen Neisseria meningitidis. Genetics 166: 25-32.
163. Barry, J.D. & R. McCulloch . 2001. Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite. Adv. Parasitol. 49: 1-70.